These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 26092961)
1. Medication management for left ventricular assist device thrombosis. Hohner E; Crow J; Moranville MP Am J Health Syst Pharm; 2015 Jul; 72(13):1104-13. PubMed ID: 26092961 [TBL] [Abstract][Full Text] [Related]
2. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management. Jennings DL; Weeks PA Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333 [TBL] [Abstract][Full Text] [Related]
3. Left ventricular assist device pump thrombosis: is there a role for glycoprotein IIb/IIIa inhibitors? Bellumkonda L; Subrahmanyan L; Jacoby D; Bonde P ASAIO J; 2014; 60(1):134-6. PubMed ID: 24335386 [TBL] [Abstract][Full Text] [Related]
4. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of Various Treatment Strategies for Patients with Continuous-Flow Ventricular Assist Device Thrombosis: A Retrospective Analysis. Ertugay S; Engin C; Daylan A; Pektok E; Ozturk P; Nalbantgil S; Zoghi M; Yagdi T; Ozbaran M ASAIO J; 2016; 62(5):533-8. PubMed ID: 27258228 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review. Baumann Kreuziger LM; Kim B; Wieselthaler GM J Thromb Haemost; 2015 Jun; 13(6):946-55. PubMed ID: 25845489 [TBL] [Abstract][Full Text] [Related]
7. What is the optimal anticoagulation in patients with a left ventricular assist device? Rossi M; Serraino GF; Jiritano F; Renzulli A Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118 [TBL] [Abstract][Full Text] [Related]
9. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management. Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964 [TBL] [Abstract][Full Text] [Related]
10. Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis. Upshaw JN; Kiernan MS; Morine KJ; Kapur NK; DeNofrio D ASAIO J; 2016; 62(1):33-9. PubMed ID: 26479464 [TBL] [Abstract][Full Text] [Related]
11. The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices. Bitar A; Vijayakrishnan R; Lenneman A; Birks E; Massey T; Slaughter M; Abramov D Artif Organs; 2017 Dec; 41(12):1092-1098. PubMed ID: 28621461 [TBL] [Abstract][Full Text] [Related]
12. Medical Management of Pump-Related Thrombosis in Patients with Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. Dang G; Epperla N; Muppidi V; Sahr N; Pan A; Simpson P; Baumann Kreuziger L ASAIO J; 2017; 63(4):373-385. PubMed ID: 27984314 [TBL] [Abstract][Full Text] [Related]
13. Limited Efficacy of Thrombolytics for Pump Thrombosis in Durable Left Ventricular Assist Devices. Seese L; Hickey G; Keebler M; Thoma F; Kilic A Ann Thorac Surg; 2020 Dec; 110(6):2047-2054. PubMed ID: 32348739 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics. Kamouh A; John R; Eckman P Ann Thorac Surg; 2012 Jul; 94(1):281-3. PubMed ID: 22734996 [TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy for durable left ventricular assist devices: protocol for a living systematic review with indirect comparison/network meta-analysis. Derzi SH; Dewidar O; Sabri H; Tran D; Wells GA BMJ Open; 2024 Jun; 14(6):e080110. PubMed ID: 38925683 [TBL] [Abstract][Full Text] [Related]
16. Minimally Invasive LVAD Deactivation in a 65-Year-Old Man with Recurrent Pump Thrombosis and Left Ventricular Recovery. Pendyal A; Chien CV; Mudd JO; Gelow JM Tex Heart Inst J; 2017 Feb; 44(1):70-72. PubMed ID: 28265218 [TBL] [Abstract][Full Text] [Related]
17. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy. Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. Thomas MD; Wood C; Lovett M; Dembo L; O'Driscoll G J Heart Lung Transplant; 2008 Aug; 27(8):925-7. PubMed ID: 18656810 [TBL] [Abstract][Full Text] [Related]
19. Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices. Baumann Kreuziger LM J Thromb Thrombolysis; 2015 Apr; 39(3):337-44. PubMed ID: 25549823 [TBL] [Abstract][Full Text] [Related]
20. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events. Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]